Armata Pharmaceuticals
ARMP
16 hedge funds and large institutions have $532K invested in Armata Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 0 closing their positions.
14% more funds holding
Funds holding: 14 → 16 (+2)
9% more capital invested
Capital invested by funds: $486K → $532K (+$46K)
0.33% more ownership
Funds ownership: 1.32% → 1.65% (+0.33%)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Edgewood Management
Greenwich,
Connecticut
|
+$80.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$59.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$837 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$6.04K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.13K |
| 3 |
Morgan Stanley
New York
|
-$946 |
| 4 |
BlackRock
New York
|
-$443 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$201 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $241K | -$6.04K | -1,500 | -2% |
|
2
Stifel Financial
St. Louis,
Missouri
| $73K | – | – | – |
|
|
3
Edgewood Management
Greenwich,
Connecticut
| $65K | +$80.5K | +20,000 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $49K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $48K | +$59.1K | +14,688 | New |
|
|
6
BlackRock
New York
| $35K | -$443 | -110 | -1% |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $8K | – | – | – |
|
|
8
Morgan Stanley
New York
| $6K | -$946 | -235 | -11% |
|
|
9
UBS Group
Zurich,
Switzerland
| $3K | +$837 | +208 | +36% |
|
10
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $2K | – | – | – |
|
|
GWM
11
Geneos Wealth Management
Englewood,
Colorado
| $1K | – | – | – |
|
|
TWA
12
TCI Wealth Advisors
Tucson,
Arizona
| $1K | – | – | – |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$4.13K | -1,025 | -99% |
|
|
14
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$201 | -50 | -31% |
|
ARMP Hedge Fund Activity: Q4 2019 in Review
16 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q4 2019, worth a combined $532K — up 9.5% from $486K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ARMP positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 5 trimmed.
The largest buyer was Edgewood Management, opening a new position worth an estimated $80.5K. The largest seller was Renaissance Technologies, cutting an estimated $6.04K.
- 16 institutional investors held Armata Pharmaceuticals (ARMP) as of Q4 2019, up from 14 in Q3 2019.
- Funds reported $532K of Armata Pharmaceuticals stock for Q4 2019, up 9.5% quarter-over-quarter.
- 2 funds opened new Armata Pharmaceuticals positions in Q4 2019 and 0 closed out, a net change of +2 holders.
- The largest Armata Pharmaceuticals buyer in Q4 2019 was Edgewood Management, an estimated $80.5K added.
- The largest Armata Pharmaceuticals seller in Q4 2019 was Renaissance Technologies, an estimated $6.04K sold.
Based on aggregated 13F filings for Q4 2019.